Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nader E Abo-Dya

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Current Medicinal Chemistry|August 15, 2023
Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR ReviewKamel Metwally, Nader E Abo-Dya
European Journal of Medicinal Chemistry|September 13, 2025
Drugging the undruggable: Chemical and biological insights into molecular glues in the pipelineKamel Metwally, Galal Yahya, Nader E Abo-Dya
Acta Crystallographica. Section E, Structure Reports Online|January 4, 2013
1-(Benzotriazol-1-yl)-2-bromoethanoneAbdullah M Asiri, Nader E Abo-Dya, Muhammad Nadeem Arshad, et al.
Microorganisms|September 27, 2025
Phytochemicals from <i>Euclea natalensis</i> Modulate Th17 Differentiation, HIV Latency, and Comorbid Pathways: A Systems Pharmacology and Thermodynamic Profiling ApproachErnest Oduro-Kwateng, Nader E Abo-Dya, Mahmoud E Soliman, et al.
Toxicology and Applied Pharmacology|May 13, 2026
Paroxetine attenuates doxorubicin-induced cardiotoxicity: Integrated network pharmacology, molecular modeling, and in vivo evidence consistent with modulation of GRK2/iNOS-related pathwaysMahmoud Nabil, Rasha Abdel-Ghany, Nader E Abo-Dya, et al.
Organic & Biomolecular Chemistry|April 8, 2010
The chemical ligation of selectively S-acylated cysteine peptides to form native peptides via 5-, 11- and 14-membered cyclic transition statesAlan R Katritzky, Nader E Abo-Dya, Srinivasa R Tala, et al.
Journal of Molecular Modeling|October 12, 2022
Battling BTK mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations in Waldenström macroglobulinemia therapy: structural mechanistic insights on the role of fenebrutinibGhazi Elamin, Aimen Aljoundi, Mohamed Issa Alahmdi, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 8, 2023
Revealing the Role of the Arg and Lys in Shifting Paradigm from BTK Selective Inhibition to the BTK/HCK Dual Inhibition - Delving into the Inhibitory Activity of KIN-8194 against BTK, and HCK in the Treatment of Mutated <i>BTK</i><sup>Cys481</sup> Waldenström Macroglobulinemia: A Computational ApproachGhazi Elamin, Aimen Aljoundi, Mohamed I Alahmdi, et al.
Acta Crystallographica. Section E, Structure Reports Online|January 4, 2013
1-(1H-1,2,3-Benzotriazol-1-yl)-2-(4-meth-oxy-phen-yl)ethanoneAbdullah M Asiri, Nader E Abo-Dya, Muhammad Nadeem Arshad, et al.
Amino Acids|April 5, 2013
Photophysics of novel coumarin-labeled depsipeptides in solution: sensing interactions with SDS micelle via TICT modelSuvendu Biswas, Ilker Avan, Akash K Basak, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Current Medicinal Chemistry|August 15, 2023
Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR ReviewKamel Metwally, Nader E Abo-Dya
European Journal of Medicinal Chemistry|September 13, 2025
Drugging the undruggable: Chemical and biological insights into molecular glues in the pipelineKamel Metwally, Galal Yahya, Nader E Abo-Dya
Acta Crystallographica. Section E, Structure Reports Online|January 4, 2013
1-(Benzotriazol-1-yl)-2-bromoethanoneAbdullah M Asiri, Nader E Abo-Dya, Muhammad Nadeem Arshad, et al.
Microorganisms|September 27, 2025
Phytochemicals from <i>Euclea natalensis</i> Modulate Th17 Differentiation, HIV Latency, and Comorbid Pathways: A Systems Pharmacology and Thermodynamic Profiling ApproachErnest Oduro-Kwateng, Nader E Abo-Dya, Mahmoud E Soliman, et al.
Toxicology and Applied Pharmacology|May 13, 2026
Paroxetine attenuates doxorubicin-induced cardiotoxicity: Integrated network pharmacology, molecular modeling, and in vivo evidence consistent with modulation of GRK2/iNOS-related pathwaysMahmoud Nabil, Rasha Abdel-Ghany, Nader E Abo-Dya, et al.
Organic & Biomolecular Chemistry|April 8, 2010
The chemical ligation of selectively S-acylated cysteine peptides to form native peptides via 5-, 11- and 14-membered cyclic transition statesAlan R Katritzky, Nader E Abo-Dya, Srinivasa R Tala, et al.
Journal of Molecular Modeling|October 12, 2022
Battling BTK mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations in Waldenström macroglobulinemia therapy: structural mechanistic insights on the role of fenebrutinibGhazi Elamin, Aimen Aljoundi, Mohamed Issa Alahmdi, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 8, 2023
Revealing the Role of the Arg and Lys in Shifting Paradigm from BTK Selective Inhibition to the BTK/HCK Dual Inhibition - Delving into the Inhibitory Activity of KIN-8194 against BTK, and HCK in the Treatment of Mutated <i>BTK</i><sup>Cys481</sup> Waldenström Macroglobulinemia: A Computational ApproachGhazi Elamin, Aimen Aljoundi, Mohamed I Alahmdi, et al.
Acta Crystallographica. Section E, Structure Reports Online|January 4, 2013
1-(1H-1,2,3-Benzotriazol-1-yl)-2-(4-meth-oxy-phen-yl)ethanoneAbdullah M Asiri, Nader E Abo-Dya, Muhammad Nadeem Arshad, et al.
Amino Acids|April 5, 2013
Photophysics of novel coumarin-labeled depsipeptides in solution: sensing interactions with SDS micelle via TICT modelSuvendu Biswas, Ilker Avan, Akash K Basak, et al.
Pageof 4